X0306 4 2022-10-03 0 0001398659 Genpact LTD G 0001408239 Tyagarajan N. V. C/O GENPACT LLC 1155 AVENUE OF THE AMERICAS, 4TH FLOOR NEW YORK NY 10036 1 1 0 0 President and CEO Common Shares 2022-10-03 4 M 0 50000 19.35 A 694377 D Common Shares 2022-10-03 4 S 0 49700 44.4686 D 644677 D Common Shares 2022-10-03 4 S 0 300 43.753 D 644377 D Common Shares 2022-10-04 4 M 0 50000 19.35 A 694377 D Common Shares 2022-10-04 4 S 0 50000 45.6565 D 644377 D Common Shares 2022-10-05 4 M 0 50000 19.35 A 694377 D Common Shares 2022-10-05 4 S 0 50000 45.8093 D 644377 D Common Shares 10000 I By Trust Employee Stock Option (Right to Buy) 19.35 2022-10-03 4 M 0 50000 0 D 2023-05-30 Common Shares 50000 1450000 D Employee Stock Option (Right to Buy) 19.35 2022-10-04 4 M 0 50000 0 D 2023-05-30 Common Shares 50000 1400000 D Employee Stock Option (Right to Buy) 19.35 2022-10-05 4 M 0 50000 0 D 2023-05-30 Common Shares 50000 1350000 D The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.91 to $44.84. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average price. The actual sales price for these transactions ranged from $45.00 to $45.93. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average price. The actual sales price for these transactions ranged from $45.46 to $46.12. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein. The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. /s/ Thomas D. Scholtes, as Attorney-in-fact for N.V. Tyagarajan 2022-10-05